Issues related to coverage of pharmaceutical products
Registered Lobbyists (1)
DANA SINGISER ●NEW— Issues regarding contraceptive healthcare campaign and Right to Contraception Act
IDs
Filing UUID:e6572de7-410b-49cf-b2b2-f01f5524a5f9
Registrant ID:401110199
Client ID:70591
2026-01-12
BGR GOVERNMENT AFFAIRS
PFIZER, INC
$0
$0
Filing Details
Type: ld2 • Year: 2026 Q1
Specific Issues
Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally and/or Pfizer specifically.
Government Entities
Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (9)
BRENT DEL MONTE — Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce CommitteeCHRIS KELLY — Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst. Sen. BlackburnDANIEL FARMER — Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack SpaceJOEL BAILEY — COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. RahallJOHN STONE — Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&CMARVIN FIGUEROA — COS, Sen. Laphonza Butler; Dir. of Off. of Inter. Affairs and Ext. Affairs, HHS; Sen. Policy Adv., Leg. Asst., Leg. Aide, Leg. Corr., Sec. Edu. Grad. Fellow, Sen. Mark Warner; Intern, White HouseRAGHAV AGGARWAL — Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of InteriorREMY MASON — Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson SchwartzROBERT WOOD — Chief of Staff to HHS Secretary; Intern to Rep. Scott Klug
IDs
Filing UUID:2db1d393-b505-448f-89b1-89597eb5cacf
Registrant ID:5357
Client ID:106343
2026-01-12
BGR GOVERNMENT AFFAIRS
NEUROCRINE BIOSCIENCES, INC.
$0
$0
Filing Details
Type: ld2 • Year: 2026 Q1
Specific Issues
Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally such as drug pricing and telehealth policy
Government Entities
Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (9)
BRENT DEL MONTE — Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce CommitteeDANIEL FARMER — Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack SpaceJOEL BAILEY — COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. RahallJOHN STONE — Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&CMARVIN FIGUEROA — COS, Sen. Laphonza Butler; Dir. of Off. of Inter. Affairs and Ext. Affairs, HHS; Sen. Policy Adv., Leg. Asst., Leg. Aide, Leg. Corr., Sec. Edu. Grad. Fellow, Sen. Mark Warner; Intern, White HouseRAGHAV AGGARWAL — Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of InteriorREMY MASON — Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson SchwartzROBB WALTON — Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. NunesROBERT WOOD — Chief of Staff to HHS Secretary; Intern to Rep. Scott Klug
IDs
Filing UUID:97f53de5-92ac-485e-8e52-75320aeafe00
Registrant ID:5357
Client ID:106706
2026-01-12
BGR GOVERNMENT AFFAIRS
WALGREEN CO.
$0
$0
Filing Details
Type: ld2 • Year: 2026 Q1
Specific Issues
Provide policy analysis, strategic advice and direct advocacy support to Walgreens related to public policy priorities for the retail pharmacy industry
Government Entities
Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (9)
BRENT DEL MONTE — Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce CommitteeCHRIS KELLY — Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst. Sen. BlackburnDANIEL FARMER — Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack SpaceJOEL BAILEY — COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. RahallJOHN STONE — Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&CMARVIN FIGUEROA ●NEW— COS, Sen. Laphonza Butler; Dir. of Off. of Inter. Affairs and Ext. Affairs, HHS; Sen. Policy Adv., Leg. Asst., Leg. Aide, Leg. Corr., Sec. Edu. Grad. Fellow, Sen. Mark Warner; Intern, White HouseRAGHAV AGGARWAL — Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of InteriorREMY MASON — Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson SchwartzROBB WALTON — Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes
IDs
Filing UUID:9b25d84e-e453-45cb-a198-0491ca121cd7
Registrant ID:5357
Client ID:106757
2026-01-08
FORWARD GLOBAL
FARUK CAPAN ON BEHALF OF IT'S ALL GOOD, LLC
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Drug pricing reform, pharmaceutical advertising, use of AI in healthcare.
Registered Lobbyists (4)
AVA COFIELL ●NEWLIZZY IRWIN ●NEWNICK BONFIGLIO ●NEWTHOMAS MATHIASEN ●NEW
IDs
Filing UUID:53bc64e9-bb5f-48e4-b87b-c172d0e7c271
Registrant ID:401105597
Client ID:70452
2026-01-06
VENABLE LLP
AMERICAN ASSOCIATION OF PSYCHIATRIC PHARMACISTS
$30,000
$0
Filing Details
Type: ld2 • Year: 2025 Q4
Specific Issues
Increasing access to mental health and substance use treatment, including via telehealth; Mental health & substance use disorder workforce; Federal funding for mental health and substance use programs, research and training; Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; H.R. 2483, Reauthorization of Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act; H.R. 2509/S. 931, Connecting Our Medical Providers with Links to Expand Tailored and Effective (COMPLETE) Care Act; Transparency and streamline utilization management protocols including prior authorization and step therapy (H.R. 8702/S. 4532); Preventing and reducing suicide; Medicare Part B coverage of pharmacist provided patient care services; Occupational Therapy Mental Health Parity Act (H.R. 4037/S. 2847).
DOUGLAS HUYNHKEATON HIGGINS ●NEWMICHAEL BAXTER ●NEW
IDs
Filing UUID:4d31eee0-6423-40e8-9da7-4e5abff32881
Registrant ID:3071
Client ID:103628
2026-01-06
AMERICAN COLLEGE OF CLINICAL PHARMACY
AMERICAN COLLEGE OF CLINICAL PHARMACY
$0
$144,981
Filing Details
Type: ld2 • Year: 2025 Q4
Specific Issues
Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs.; Promote enhanced quality, structure and information dissemination concerning medication therapy management services (MTMS) under Medicare Part D.; Promote greater medication safety and more appropriate medication use through more active involvement of pharmacists in patient care.; Seek restoration of Medicare funding for specialized residency training under Medicare prospective payment rules. Seek pharmacist participation in National Health Service Corps (NHSC) loan repayment programs. Support development of inter-professional health education programs by working with Congress to make programs authorized under Title VII of the Public Health Service Act a significant aspect of comprehensive health professions education.; Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans.
Government Entities
HOUSE OF REPRESENTATIVES, SENATE, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA)
Registered Lobbyists (2)
JOHN MCGLEW — Senior Director, Government AffairsKATHERINE PHAM — Senior Director, Policy and Professional Affairs
IDs
Filing UUID:fdc9720a-30cd-4f38-b544-e86228eaa7d1
Registrant ID:57258
Client ID:159980
2026-01-05
CORNERSTONE GOVERNMENT AFFAIRS, INC.
ABBVIE INC.
$60,000
$0
Filing Details
Type: ld2 • Year: 2025 Q4
Specific Issues
International tax issues and pharmaceutical pricing and access issues, and patent issues.; International tax issues and pharmaceutical pricing and access issues, and patent issues.
Government Entities
HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (5)
JOHN CRUMBLISSJOHN SANDELL — Tax Counsel, Legislative Assistant; Ways and Means Committee (Camp, Ryan, Brady)MICHAEL GOODMAN — Chief of Staff House Member Office (Kind), Legislative Staff House Member Office (Braley, Barrow)STACY RICH — Leadership Staff Director, Senior Leadership Advisor and Floor Director, Leadership Advisor (Senate -Murray); Senate Cloakroom Asst, Dem Cloakroom (Reid, Daschle); Staff/Press Asst (Daschle)TODD WEBSTER — Communications Senate Member Office (Murray, Daschle), Chief of Staff Senate Member Office (Coons)
Advocate on concerns relating to intrusion of government mandates into commercial insurance marketplace for pharmacy benefits managers; advocate concerns and proper consideration of Medicaid Part D provisions in legislative packages including proposed year-end ACA subsidy bill. Monitor relevant committee hearings on PBM legislation.
Government Entities
HOUSE OF REPRESENTATIVES
Registered Lobbyists (1)
RYAN COSTELLO — US Congressman, 2015-2019 (PA-6)
IDs
Filing UUID:287cdb8b-f1f4-43ad-b477-f5cadffc19bd
Registrant ID:401105569
Client ID:56881
2026-01-01
TAUZIN STRATEGIC NETWORKS
RAZORMETRICS
$37,500
$0
Filing Details
Type: ld2 • Year: 2025 Q4
Specific Issues
Lowering Medicare & Medicaid pharmaceutical spend with advanced cost containment systems; Lowering Medicare & Medicaid pharmaceutical spend with advanced cost containment systems
Government Entities
Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (1)
W.J. TAUZIN
IDs
Filing UUID:02acdad5-c2d5-41b7-98a0-aa060dddeb3e
Registrant ID:400786367
Client ID:64818
2025-12-22
PARATEK PHARMACEUTICALS
PARATEK PHARMACEUTICALS
$0
$20,000
Filing Details
Type: ld2 • Year: 2025 Q4
Specific Issues
FY 26 DOD Appropriations FY 26 HHS Appropriations Biodefense Funding
Government Entities
Defense, Dept of (DOD), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (1)
BENJAMIN NOVAK
IDs
Filing UUID:e16b81e7-fcd1-4a8f-ba38-e53d94af8c7a
Registrant ID:401109327
Client ID:64825
2025-12-22
ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q4
Specific Issues
Issues related to pharmaceutical manufacturing; Issues related to pharmaceutical manufacturing; Issues related to pharmaceutical manufacturing
Registered Lobbyists (1)
DEREK NATEN ●NEW
IDs
Filing UUID:7c374d64-bf14-4a5a-8193-8e52b5a1e5e8
Registrant ID:401095056
Client ID:197768
2025-12-22
CROSSROADS STRATEGIES, LLC
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA AG
$0
$0
Filing Details
Type: ld2 • Year: 2025 Q4
IDs
Filing UUID:c6902418-dcd3-44ef-ab12-a3b66596c416
Registrant ID:400531586
Client ID:56397
2025-12-17
MR. DAVID FRIEDMAN
TEVA PHARMACEUTICALS USA, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q4
Specific Issues
Issues related to strengthening the domestic supply and manufacture of essential medicines.; Issues related to strengthening the domestic supply and manufacture of essential medicines.
Registered Lobbyists (1)
DAVID FRIEDMAN ●NEW— United States Ambassador to Israel, 2017-2021
IDs
Filing UUID:97b0efa1-dc2e-4b8e-b4be-08932e46042e
Registrant ID:401110165
Client ID:70210
2025-12-17
SANDLER, TRAVIS & ROSENBERG, P.A.
SIMTRA BIOPHARMA SOLUTIONS
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q4
Specific Issues
Tariff Mitigation
Registered Lobbyists (2)
DAVID OLAVE ●NEWRANDI LEVINAS ●NEW
IDs
Filing UUID:536a5754-a822-443c-9ec8-24dc1a60739c
Registrant ID:34295
Client ID:70212
2025-12-15
DLA PIPER LLP (US)
AVALYN PHARMA INC.
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q4
Specific Issues
Issues related to rare disease.; Issues related to rare disease.
Registered Lobbyists (4)
KARINA LYNCH ●NEWMAREN MCBRIDE ●NEW— Counsel, Rep. MollohanMARGARET MARTIN ●NEW— Senior FDA Policy Advisor, Senate Health, Education, Labor and Pensions Committee; Health Policy Assistant, Sen. Richard BurrRICHARD BURR ●NEW— U.S. Senator
IDs
Filing UUID:a3f6fae7-3b52-4cbb-8d71-494fa14b465f
Registrant ID:76855
Client ID:70145
2025-12-09
BALLARD PARTNERS
MADRIGAL PHARMACEUTICALS, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q4
Specific Issues
Advocacy related to prescription drug access and pricing.
Registered Lobbyists (3)
ALISON ANWAY ●NEW— LA to Senator Pat Roberts 2006-2010BRIAN BALLARD ●NEWTRACIE POUGH ●NEW— Chief of Staff to U.S. Representative Debbie Wasserman Schultz 2003-2008 & 2009-2025 (Lobbying does not include House Appropriations)
IDs
Filing UUID:d6df130b-08a0-4735-ba41-03ce1cb49103
Registrant ID:401104288
Client ID:70096
2025-12-01
THE NICKLES GROUP, LLC
JAZZ PHARMACEUTICALS, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q4
Specific Issues
Issues related to prescription drugs. Most Favored Nation drug pricing. Regulation of cannabinoids.; Issues related to prescription drugs. Most Favored Nation drug pricing. Regulation of cannabinoids.
Registered Lobbyists (3)
BRETT BAKER ●NEW— U.S. Senate Committee on Finance (Senators Crapo, Grassley, and Hatch)-Deputy Health Policy Director; Health Policy Dir.; Senior Policy Advsr; Policy Advisor. U.S. House of Representatives Committee on Ways and Means (Reps. Camp and Ryan) Prof. StaffGREG D'ANGELO ●NEW— White House Office of Management and Budget, Associate Director of Health Programs; Senate Committee on the Budget (Sen. Gregg, Sen. Sessions, and Sen. Enzi), Professional Staff MemberMARY SAVARY TAYLOR ●NEW— Joint Economic Committee, General Counsel; U.S. Senator Connie Mack, Legislative Assistant
IDs
Filing UUID:4b17454c-c5c2-455a-93b0-c35104be05fe
Registrant ID:293335
Client ID:69994
2025-11-26
THE VOGEL GROUP
AVARA PHARMACEUTICALS INC.
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q4
Specific Issues
Issues related to business operations in Oklahoma; Issues related to financial services
Registered Lobbyists (2)
ALEXANDER VOGEL ●NEW— Former Chief Counsel, Senate Majority Leader Bill FristJOHN HESSE ●NEW
IDs
Filing UUID:3f092f60-33c7-4630-983d-525a19ad40e5
Registrant ID:401104734
Client ID:69969
2025-11-21
BALLARD PARTNERS
FERRING PHARMACEUTICALS, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q4
Specific Issues
Advocacy regarding IVF access and tariffs.
Registered Lobbyists (2)
ALISON ANWAY ●NEW— LA to Senator Pat Roberts 2006-2010BRIAN BALLARD ●NEW